Venrize Academy and BBI Cambridge have formed an exclusive partnership to promote the International MBA in Life Sciences and Biotechnology in Southeast Europe across: Bulgaria, Romania, Serbia, Montenegro, North Macedonia, Albania, Kosovo, Bosna, Slovenia, Croatia, Greece and Turkey.
Venrize Academy Presents
The World's First International MBA in Life Sciences and Biotechnology
Applications now open.
The First Business School in Life Sciences and Biotechnology
The BBI is a global academic institution which providers exclusive programmes in biotechnology and life sciences. The BBI offers a truly international experience across its campuses in Cambridge and Barcelona. The programme offers a practical experience for students to work on a real world drug discovery and development projects, immerse in technology transfer, venture building and international business development. The school bridging together a bustling community of scientists, entrepreneurs, business leaders, corporates and investors with the focus on shaping the future of life sciences.
Leading Global Faculty
Beatriz Casado
Value & Access Director at Biogen
Clare Jones
Head of R&D at Talisman Theurapeutics
David Parry-Smith
Head of Cellular Informatics at Welcome Sanger Institute
Elena Gobartt
Clinical Research Manager at Boehiringer Ingelheim
Esther Riambau
Life Sciences Director at UPF Venture - Co-Founder and Board Member at Gate2Brain
Iolanda Marchueta
Project Strategy Leader at Astra Zeneca
Lubor Gaal
Senior Vice President, Head of Europe at Locust Walk
Mark Treherne
Partner, Cambridge Drug Discovery, Lecturer on Drug Discovery for over 25 years
Mark Ramondt
Co-Founder at MultiplAI
Miriam Fernandez
Senior Global Market Access Manager at Ferrer
Murat Tunaboylu
CEO at Antiverse
Prashant Shah
CEO o2h co-work labs & incubator, The Mill SciTech Park
Tim Sherwell
Head of Brexit Supply Assurance at Astra Zeneca
Salvador Gea
Health Economics Manager at Amgen
Silvia Ramirez
Healthcare Innovation, Petient Journey Strategy at Novartis
The Biotechnology MBA with True Career Impact
Our career impact program is tailored to the individual needs and aspirations of each student. Our aim is to support you throughout your career development and to help you find professional opportunities via internships, placement and full time employment. In your early days of your education expect to learn from leading executives, entrepreneurs and scientists. You will have a mentor who will help you grow you network and exposure across the Life Sciences ecosystems of Cambridge and Barcelona.
Real World Projects: IP creation
2020: A new therapy for breast tumours based on genomic characteristics
The Institute for Research in Biomedicine (IRB Barcelona) is an independent, non for-profit research center engaged in basic and applied biomedical science. The convergence of biology, chemistry, medicine, physics and computer science at IRB Barcelona provides a unique opportunity for the translation of basic biomedical research into innovation
2020: A NOVEL AND PROMISING NEW TARGET AGAINST ALZHEIMER’S DISEASE
The Institute for Research in Biomedicine (IRB Barcelona) is an independent, non for-profit research center engaged in basic and applied biomedical science. The convergence of biology, chemistry, medicine, physics and computer science at IRB Barcelona provides a unique opportunity for the translation of basic biomedical research into innovation.
2020: A new validated HTS to identify new first-in-class antitumoral compounds
RB was the first described tumor-suppressor protein and its inactivation is known to trigger a large variety of tumors
2020: NOVEL SET OF MARKERS TO SELECT ACTIVE ADIPOSE STEM CELLS (ASC) FOR IMPROVING EFFICACY OF CELL THERAPY
Cell therapy with mesenchymal stem cells (MSCs) has been described as a promising clinical strategy for regenerative medicine due to their immunosuppressive and tissue repair properties.
2020: PORTABLE DEVICE FOR MOLECULAR DIAGNOSIS (PDMD)
A research group, with wide experience on microelectronics and on the development of measure and image system, has generated a portable device for a low-cost molecular diagnosis based on the measurement of samples’ fluorescence
2018: ONCOSELECTIVE MECHANISM FOR GENE OR VIRAL THERAPY
The Institute for Research in Biomedicine (IRB Barcelona) is an independent, non for-profit research center engaged in basic and applied biomedical science. The convergence of biology, chemistry, medicine, physics and computer science at IRB Barcelona provides a unique opportunity for the translation of basic biomedical research into innovation.
2017: Novel cost saviNg catalysts for asymmetric hyrogeNatioN of eNamides
The Institute for Research in Biomedicine (IRB Barcelona) is an independent, non for-profit research center engaged in basic and applied biomedical science. The convergence of biology, chemistry, medicine, physics and computer science at IRB Barcelona provides a unique opportunity for the translation of basic biomedical research into innovation
Spinout Companies
Students work on real world IP, and company spinouts with leading TTOs.
CHECK OUT SOME OF THE COMPANIES THAT HAVE BEEN CREATED DURING THE MBA PERIOD AND HAVE BEEN PART OF THE ANNUAL THESIS
Alumni
94% of our students find an internship or a new job opportunity within their MBA year.
Beatriz Witllin
5th Ed. Global MBA - Associate Medical Affairs Director, European Medical Reasearch Liason at Argenx, Berlin
Antonio Herce
2th Ed. Global MBA - Investment analyst - Life Sciences at Inveready, Barcelona
Giacomo De Simone
Head of Innovation at Vali dHebron Institute of Reasearch (VHIR), Barcelona, Spain
Marina Miel Dayrit
Alliance Regional Manager at Menarini Asia-Pacific, Manila, Philipines
Aina Marcos
3rd Ed. Global MBA - Innovation Manager en Trifermed
Andreina de Leon
Omnichannel at Novartis, London, United Kingdom
Beatriz Volckaert
4th Ed. Global MBA - Impact Investment Analyst at Ship2B
Camila Pazos
Pharma RWE Sales Manager EU at LynxCare, Barcelona & Brussels
Gemma Guinart
4th Ed. Global MBA - Investment Analyst en Invivo Capital
Gloriana Solano
Research Analyst at Jupiter Life Science Consulting, Costa Rica
Halynn Ringstad
1st Ed. Global MBA - Project Leader at Parexel, North Carolina, USA
Ignacio Prieto
Tech Transfer Funds Analyst en Clave Capital, Pamplona, Spain
Maida Ahmed
3rd Ed. Global MBA - Rotational Expert at Roche Diabetes Care
Iraida Soria
3rd Ed. Global MBA - Senior Innovation and Business Manager at UK Dementia Research Institute, Oxford
Mar Eroles
2nd Ed. Global MBA - Founder of Mandarina Capital
Maria Zimina
Business Development Manager at SOM Biotech, Barcelona, Spain
Maria Cavaller
Patient Engagement at EURORDIS - Rare Diseases Europe, Barcelona, Spain
Mireia Lopez
Business Development at GoodGut
Marta Aguado
6th Ed. Global MBA - HEOR analyst at AliraHealth, Barcelona
Rebeca Kenda Nana
3rd Ed. Global MBA - Market Access, Senior Analyst at Research Partnership London
Pau Monroy
Transactions Analyst at Locust Walk, London, United Kingdom
Sara Torrecilla
4th Ed. Global MBA - Healthcare Funds Analyst at Candriam, Brussels
Members in our Community
Drug Development plans delivered
Companies involved in our programmes
Equip Yourself With World Class Knowledge
The International MBA course in Life Sciences is flexible and will make an important contribution to developing the next generation of talent worldwide.
Dr. Mark Treherne Partner, Cambridge Drug Discovery
The International MBA Life Sciences aims to provide a flexible bridge between academic talent with real life commercial healthcare development. Using global key opinion leaders and professors to harmess the next generation of life science stakeholders.
Chris Howie Founder, Investor and Life Science Business Advisors
With the MBA you will able to meet and work with an international panel of lectures and experts in global leadership and management.
Roop Chandwani CEO at Mazards
The MBA has given me the opportunity to learn in a very flexible manner and interact with a broad international panel of visiting lectures and experts in Life Sciences mentors during the BBI career impact programme.
Marcos Casado MBA Candicate, Intership Program at EIT Health
The International MBA with the Market Access specialisation allowed me to understand how new drugs and products are developed in the healthcare industry, The BBI career impact development programme during academic year also helped me to expand my network internationally. I really benefited from the experience of working between Barcelona and London, which has increased my professional opportunities globally.
Rebeca Kenda Associate Consultant
During the BBI career impact program I had the opportunity to understand the global Life Science sector and focus my development towards my professional objectives. The skills developed added to an increase of my network was key to start my career in management.
German Deza MBA Candidate, Intership Program at Inveniam
For our Bulgarian ecosystem is a great opportunity to welcome and support in our region the World's first international MBA in Life Sciences and Biotechnology. By joining forces of Venrize Academy and BBI Cambridge we can ensure well-trained leaders of life sciences, providing them with business skills, scientific critical thinking.
Kristina Eskenazi Chair of the Health & Life Sciences Cluster Bulgaria
I am delighted to hear that the BBI has chosen to expand its reach to Bulgaria and the Southeast European regions. I believe that by bringing the entrepreneurial spirit of Cambridge, Europe's most advanced biotechnology cluster, the programme will ignite interest in the sector and produce innovation which will save many human lives.
